Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma

Br J Haematol. 2018 Sep;182(5):733-735. doi: 10.1111/bjh.14864. Epub 2017 Aug 31.

Authors

Lara Mussolin^{1

2}, Marta Pillon¹, Martin Zimmermann¹, Elisa Carraro¹, Giuseppe Basso¹, Fabian Knoerr³, Wilhelm Woessmann³, Christine Damm-Welk³

Affiliations

¹ Department of Women's and Children's Health, Clinic of Paediatric Haemato-Oncology, University of Padova, Padova, Italy.
² Istituto di Ricerca Pediatrica, Fondazione Città della Speranza, Padova, Italy.
³ NHL-BFM Study Centre and Department of Paediatric Haematology and Oncology, Justus-Liebig-University, Giessen, Germany.

PMID: 28857122
DOI: 10.1111/bjh.14864

No abstract available

Keywords: anaplastic large cell lymphoma; anti-ALK; antibody titre; childhood; non Hodgkin lymphoma.

MeSH terms

Adolescent
Anaplastic Lymphoma Kinase / immunology*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Autoantibodies / blood*
Biomarkers, Tumor / blood
Child
Child, Preschool
Female
Humans
Kaplan-Meier Estimate
Lymphoma, Large-Cell, Anaplastic / drug therapy*
Lymphoma, Large-Cell, Anaplastic / immunology
Male
Remission Induction

Substances

Autoantibodies
Biomarkers, Tumor
Anaplastic Lymphoma Kinase